Study ID: FSS-AS-30003 | 2016-003835-39
Study Title
- Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Teva Identifier
- FSS-AS-30003 | 2016-003835-39
ClinicalTrials.gov Identifier
- NCT02980133
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Fluticasone Propionate | Drug: Fluticasone Propionate/Salmeterol | Drug: Placebo MDPI
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years to 11 Years
Trial Duration
- December 28, 2016 - April 13, 2019
Phase
- Phase 3
Additional info
Study Type
Interventional
